Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University

Size: px
Start display at page:

Download "Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University"

Transcription

1 Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University

2 Dosage forms Sterile Free from all forms of microbial life (vegetative & sporing) Free from pathogens Non-sterile Extent of total bioburden

3 Dosage forms Sterile Injections (parentrals) Ophthalmic Products Non-sterile All other routes of administration

4 Dosage forms Solid Liquid Semi-solid Powder Suppository Pessary Inserts Sponges Microparticles Nanoparticles Liposomes Films Solution Suspension Emulsion Microemulsion Nanoemulsion Nanosuspension In-situ gels Cream Ointment Paste Gel

5 Dosage forms Solid Liquid Semi-solid Advantages *Easy to use *Suitable for most routes of administration *Fast onset of action Disadvantages *Need for dose measurement *Short duration of action *Bulky to carry and store *Liability of drugs to degradation *Liable to microbial growth

6 Dosage forms Solid Liquid Semi-solid Advantages *Accurate dose *Easier to carry and store *More drug stability *No preservation requirements *Suitable for fast and extended drug release Disadvantages *Not for all routes of administration *Less convenient for administration for some patients *More complex and expensive manufacture

7 Liquid Dosage forms Solution Suspension Emulsion

8 Liquid Dosage forms Solution Suspension Emulsion Suspending agent O/W W/O

9 Liquid Dosage forms Solution Suspension Emulsion Deflocculated Flocculated

10 Liquid Dosage forms Solution Suspension Emulsion

11 Liquid Dosage forms Solution Suspension Emulsion Advantages *Dose uniformity *Easy to prepare *Suitable for all routes of adminstration *Fast onset of action *Easy to use Disadvantages *Not for insoluble drugs *Not for oral bitter drugs *Short duration of action *Bulky to carry *Liability of drugs to degradation *Need for dose measurement *Liable to microbial growth

12 Liquid Dosage forms Solution Suspension Emulsion Advantages *For insoluble drugs *For bitter drugs *Longer duration of action *Better chemical stability *Suitable for most routes of administration *Easy to use Disadvantages *Risk of dose variation *More difficult to prepare *Physical instability issues *Bulky to carry *Need for dose measurement *Liable to microbial growth

13 Liquid Dosage forms Solution Suspension Emulsion Advantages *For insoluble drugs *For bitter drugs *More chemical drug stability *Longer duration of action *Improved absorption *Suitable for most routes of administration *Easy to use Disadvantages *More difficult to prepare *Physical instability *Risk of rancidity *Bulky to carry *Need for dose measurement *Liable to microbial growth

14 Liquid Dosage forms Solution Excepients: Solvent Solubilizing agents Preservatives Antioxidants Buffer Sweetening agents Flavoring agents Coloring agent Suspension Excepients: Suspension medium Suspending agents Wetting agents Viscosity adjusters Preservatives Antioxidants Buffer Sweetening agents Coloring agent Emulsion Excepients: Aqueous solvent Oily phase Emulsifying agents Preservatives

15 Liquid Dosage forms Solution Suspension Emulsion Aqueous Non aqueous Oily Injections Hydroalcoholic Elixirs

16 Liquid Dosage forms Solution Suspension Emulsion Aqueous Oily

17 Liquid Dosage forms Solution Suspension Emulsion W/O O/W

18 Liquid Dosage forms Solution Suspension Emulsion Liquid Semi-solid Ointment Suppository

19 Liquid Dosage forms Solution Suspension Emulsion Liquid Semi-solid cream ointment

20 Solid Dosage forms Used as powder To be reconstituted Solution Suspension

21 Solid Dosage forms Bulk powder Divided powders

22 Solid Dosage forms Aggregates of powdered materials (2-4 mm) To be reconstituted

23 Solid Dosage forms Conventional release Controlled release Extended Delayed (enteric)

24 Solid Dosage forms

25 Solid Dosage forms

26 Solid Dosage forms Tablet Compression

27 Solid Dosage forms Multilayer tablets

28 Solid Dosage forms Coated tablets

29 Solid Dosage forms Coated tablets Sugar coat Film coat

30 Solid Dosage forms Conventional Orodispersible Chewable Soluble Effervescent Controlled release Extended Delayed (enteric)

31 Solid Dosage forms Hard gelatin Soft gelatin

32 Solid Dosage forms Hard gelatin Soft gelatin

33 Solid Dosage forms Conventional release Controlled release Extended Delayed (enteric)

34 Solid Dosage forms

35 Solid Dosage forms Rectal Vaginal (Pessaries) Urethral

36 Solid Dosage forms Dissolve Melt Disintegrate

37 Solid Dosage forms Advantages *Dissolve and disperse more readily *For bulk amounts of drugs *Accurate dose (divided) *Easier to carry and store *More drug stability *No preservation requirements Disadvantages *Poor flowability *Hygroscopic *Ability to cake *Not for all routes of administration

38 Solid Dosage forms Advantages *Good flowability *For large amounts of drugs *More stable against moisture and caking Disadvantages *Easier to be wetted *Not for all routes of *Accurate dose (divided) administration *Easier to carry and store *More drug stability, *No preservation requirements *Suitable for fast and extended drug release

39 Solid Dosage forms Advantages *Accurate dose *Easier to carry and store *More drug stability *No preservation requirements *Suitable for fast and extended drug release *Mask bad taste of drugs Disadvantages *Slow onset of action compared to liquids *Not for all routes of administration *Less convenient for administration for some patients

40 Solid Dosage forms Advantages *Faster action than tablets *Easier to swallow *For solid, semisolid and liquid drugs *Accurate dose, *More drug stability *Easier to carry and store *No preservation requirements *Suitable for fast and extended drug release *Mask bad taste of drugs Disadvantages

41 Solid Dosage forms Advantages Disadvantages *Slow onset of action compared to liquids *Not for all routes of administration *Less convenient for administration for some patients *More complex and expensive manufacture

42 Solid Dosage forms Excepients: Fillers (diluents) Lubricant Sweetening agents Flavoring agents Coloring agent

43 Solid Dosage forms Excepients: Fillers (diluents) Lubricant Binders Sweetening agents Flavoring agents Coloring agent

44 Solid Dosage forms Excepients: Fillers (diluents) Lubricant Binders Disintegrants Sweetening agents Flavoring agents Coloring agent

45 Solid Dosage forms Excepients: Fillers (diluents) Lubricant Sweetening agents Flavoring agents Coloring agent

46 Solid Dosage forms Cocoa butter Glycerinated gelatin Polyethylene glycol Surfactant

47 Semi-solid Dosage forms Cream Ointment Paste Gel W/O emulsion O/W emulsion

48 Semi-solid Dosage forms Cream Ointment Paste Gel Hydrocarbon base Absorption base Water removable base Water soluble base

49 Semi-solid Dosage forms Cream Ointment Paste Thicker, stiffer and less penetrating than ointments Gel aqueous fatty

50 Semi-solid Dosage forms Cream Ointment Paste Gel Organic macromolecules uniformly distributed in a liquid

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs 1 Faculty of Pharmacy H-7624 Pécs, Rókus str.2. 2 Faculty of Pharmacy Department of Pharmacetical Biotechnology Department of

More information

At LATITUDE, we only do one thing, and we do it very well.

At LATITUDE, we only do one thing, and we do it very well. Formulation Experts for Insoluble Compounds At LATITUDE, we only do one thing, and we do it very well. LATITUDE Pharmaceuticals Inc. has been tackling the most difficult drug formulation challenges for

More information

Design and Dosage Form. Dr. Deny Susanti

Design and Dosage Form. Dr. Deny Susanti Design and Dosage Form Dr. Deny Susanti Example 1 Aspirin tablet is stable but not as a liquid dosage form How to design liquid form? Soluble or dispersible aspirin tablets-to be dissolved in water Note:

More information

TASTE MASKING WITH COATINGS. Coating Technology 96 October 8-9, Presented by Ralph E. Pondell Corporate Secretary

TASTE MASKING WITH COATINGS. Coating Technology 96 October 8-9, Presented by Ralph E. Pondell Corporate Secretary 96-2 TASTE MASKING WITH COATINGS Coating Technology 96 October 8-9, 1996 Presented by Ralph E. Pondell Corporate Secretary Coating Place, Inc. P.O. Box 930310 Verona, WI 53593 (608) 845-9521 When dealing

More information

CONTENTS SECTION I ESSENTIALS OF DOSAGE FORM DESIGN SECTION II SOLID DOSAGE FORMS CHAPTER 1 PREFORMULATION STUDIES CHAPTER 2 TABLETS.

CONTENTS SECTION I ESSENTIALS OF DOSAGE FORM DESIGN SECTION II SOLID DOSAGE FORMS CHAPTER 1 PREFORMULATION STUDIES CHAPTER 2 TABLETS. Contents (9) CONTENTS Preface... (v) Acknowledgement... (vii) SECTION I ESSENTIALS OF DOSAGE FORM DESIGN CHAPTER 1 PREFORMULATION STUDIES Introduction... 3 Organoleptic Properties... 5 Purity and Impurity...

More information

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1 INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1 LAB INSTRUCTORS: LECT. ANAS T ARIK NAFEA ASSIST. LECT. ZAINAB HASSAN MAHDI Definition of Industrial Pharmacy The conversion of raw materials into certain dosage

More information

CHAPTER 1 PHARMACEUTICAL INDUSTRY

CHAPTER 1 PHARMACEUTICAL INDUSTRY 1 CHAPTER 1 PHARMACEUTICAL INDUSTRY 1.1 INTRODUCTION The global pharmaceutical industry, in the last few years, has been showing interest in India pharma industry because of its sustained economic growth,

More information

PHARMACEUTICAL MANUFACTURING

PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL MANUFACTURING WHAT IS PHARMACEUTICAL MANUFACTURING IT IS THE PROCESS OF INDUSTRIAL SCALE SYNTHESIS OF PHARMACEUTICAL DRUG BY PHARMACEUTICAL COMPANIES. THE PROCESS CAN BE BROKEN DOWN INTO

More information

Formulation Development & CTM Manufacturing Services

Formulation Development & CTM Manufacturing Services Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950 VxP Pharmaprovides an extensive range

More information

Guidelines for Pharmaceutical Equivalence Requirements

Guidelines for Pharmaceutical Equivalence Requirements Guidelines for Pharmaceutical Equivalence Requirements Version 1.1 1 September 2010 Page 1 of 9 Guidelines for Pharmaceutical Equivalence Requirements Version 1.1 Drug Sector Saudi Food & Drug Authority

More information

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester 2/26/2018 Industrial Pharmacy II, Dr. rer. nat. Rebaz Ali 1 Outlines Powder flow Introduction Factor affecting

More information

Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG

Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG Formulation two meanings Process in which different ingredients, including the active

More information

PETER GREVEN Your partner for pharmaceutical excipients

PETER GREVEN Your partner for pharmaceutical excipients PETER GREVEN Your partner for pharmaceutical excipients Sustainability and the demand for renewable raw materials are becoming more and more important in many areas. As a middlesized family owned company

More information

Approaches to the formulation of poorly soluble drugs

Approaches to the formulation of poorly soluble drugs 1 Approaches to the formulation of poorly soluble drugs R. Christian Moreton, Ph.D FinnBrit Consulting ExcipientFest 2013, April 30 May 01, 2013, Baltimore, MD 2 Disclaimer The views expressed in this

More information

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow METHOCEL Cellulose Ethers A product that can do it all TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow The possibilities are endless Pharmaceutical companies are continuously

More information

DEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION

DEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION DEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION Guideline Title Development Pharmaceutics and Process Validation Legislative basis Directive 75/318/EEC as amended Date of first adoption April 1988 Date

More information

USP s Perspective on Drug Product Performance Test

USP s Perspective on Drug Product Performance Test USP s Perspective on Drug Product Performance Test Course Overview 1. The concept of in vitro dissolution Definition and application 2. Compendial dissolution/ drug release testing 3. Method development

More information

ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT. Version 4.0. Update revision : May Document Control

ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT. Version 4.0. Update revision : May Document Control ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT Version 4.0 Update revision : May 2012 Document Control Version Date 1.0 July 2004 (8 th ACSQ PPWG Meeting; Bangkok) 2.0 February 2005 (9 th ACSQ PPWG

More information

Extractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies

Extractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies Extractables & Leachables Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies Ph.D. Pfizer Global Research and Development Bethesda 23/02/2011 Thresholds and

More information

Orodispersible drug delivery systems

Orodispersible drug delivery systems Orodispersible drug delivery systems Orodispersible drug delivery systems Disintegrate and/or dissolve rapidly in the saliva without the need for water. Tablets Films Fast-dissolving tablets are designed

More information

THE PHYSICAL CHARACTERISTICS OF LYOPHILIZED TABLETS CONTAINING A MODEL DRUG IN DIFFERENT CHEMICAL FORMS AND CONCENTRATIONS

THE PHYSICAL CHARACTERISTICS OF LYOPHILIZED TABLETS CONTAINING A MODEL DRUG IN DIFFERENT CHEMICAL FORMS AND CONCENTRATIONS Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 62 No. 1 pp. 25ñ29, 2005 ISSN 0001-6837 Polish Pharmaceutical Society DRUG TECHNOLOGY THE PHYSICAL CHARACTERISTICS OF LYOPHILIZED TABLETS CONTAINING A

More information

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group Dynamic Future. Reliable Partnership. With a turnover of approximately 1 billion USD, the Aenova Group is one of the leading companies

More information

EVALUATION OF NEW FILM COATING PROCESSES AND MATERIALS

EVALUATION OF NEW FILM COATING PROCESSES AND MATERIALS EVALUATION OF NEW FILM COATING PROCESSES AND MATERIALS Inaugural-Dissertation zur Erlangung der Doktorwurde im Fachbereich Biologie, Chemie, Pharmazie der Freien Universitat Berlin vorgelegt von NANTHARAT

More information

Rahavard Tamin Pharmaceutical Co. (RTPC)

Rahavard Tamin Pharmaceutical Co. (RTPC) Rahavard Tamin Pharmaceutical Co. (RTPC) Rahavard Tamin Pharmaceutical Company adopting the latest technology in the world has succeeded in initiating optimization in the pharmaceutical industry. The monopoly

More information

Performance Testing of Novel Dosage Forms

Performance Testing of Novel Dosage Forms RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies

More information

How to Identify Critical Quality Attributes and Critical Process Parameters

How to Identify Critical Quality Attributes and Critical Process Parameters How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,

More information

THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION

THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION Pharmacopeial Forum Vol. 31(5)(Sept.-Oct. 2005) By : Mr. Seubpong Kumpusiri Mrs. Patima Maneesatid 26 May 2006 THE DISSOLUTION PROCEDURE: DEVELOPMENT

More information

Soluplus. Technical Information. October _090801e-01/Page 1 of 8. = Registered trademark of BASF group. Pharma Ingredients & Services

Soluplus. Technical Information. October _090801e-01/Page 1 of 8. = Registered trademark of BASF group. Pharma Ingredients & Services Technical Information Soluplus October 2009 03_090801e-01/Page 1 of 8 = Registered trademark of BASF group Pharma Ingredients & Services 03_090801e-01 October 2009 Page 2 of 8 Soluplus 1. Introduction

More information

The Role of Compounded Medicines in Therapy. Loyd V. Allen, Jr., Ph.D.,R.Ph. Editor-in International Journal of Pharmaceutical Compounding

The Role of Compounded Medicines in Therapy. Loyd V. Allen, Jr., Ph.D.,R.Ph. Editor-in International Journal of Pharmaceutical Compounding The Role of Compounded Medicines in Therapy Loyd V. Allen, Jr., Ph.D.,R.Ph. Editor-in in-chief International Journal of Pharmaceutical Compounding Contact Information www.ijpc.com Lallen@ijpc.com 122 N.

More information

World Excipient Market

World Excipient Market World Excipient Market Opportunities and Forecasts, 2014 2020 Published: Feb 2016 No Of pages: 116 Introduction Scope of the Report Key Benefits Key Audiences Introduction to Excipient Market Pharmaceutical

More information

FOOD AND DRUGS AUTHORITY

FOOD AND DRUGS AUTHORITY G H A N A FOOD AND DRUGS AUTHORITY GUIDELINES FOR STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED PHARMACEUTICAL PRODUCTS Document No: FDA/DRI/DER/GL-STP/2013/07 Date of First Adoption:

More information

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Approval Review of Generic Drugs Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Outline of Presentation Introduction Approval Review of Generic Drugs Equivalency review Conformity audit Conclusion

More information

Liquisolid Compacts Based Orodispersible Tablets to Enhance Solubility of Atorvastatin using Experimental Design

Liquisolid Compacts Based Orodispersible Tablets to Enhance Solubility of Atorvastatin using Experimental Design Liquisolid Compacts Based Orodispersible Tablets to Enhance Solubility of Atorvastatin using Experimental Design Raj Shah 1 *, Hardeep Banwait 2, Sahjesh Rathi 2, Pragnesh Patni 3 1. Student of Master

More information

Design and Characterization of a Novel Sugar Free Formulation of Ferrous Gluconate in Oral Vial with Plunger and Tear Off Cap (VPTC)

Design and Characterization of a Novel Sugar Free Formulation of Ferrous Gluconate in Oral Vial with Plunger and Tear Off Cap (VPTC) INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Design and Characterization of a Novel Sugar Free Formulation of Ferrous Gluconate in Oral Vial with Plunger and Tear

More information

1-6 Specifications. Andrew Chemwolo, Technical Officer, WHO Prequalification Team Medicines Assessment

1-6 Specifications. Andrew Chemwolo, Technical Officer, WHO Prequalification Team Medicines Assessment 1-6 Specifications Andrew Chemwolo, Technical Officer, WHO Prequalification Team Medicines Assessment Outline Definition Why are specifications important? Setting appropriate specifications PQT-medicines

More information

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate Ready-to-Use High Functionality Excipient Composite Offering Advantages for Total Cost Savings Superior

More information

EDQM Standard Terms. Internal controlled vocabularies for pharmaceutical dose forms. Version January 2018

EDQM Standard Terms. Internal controlled vocabularies for pharmaceutical dose forms. Version January 2018 EDQM Standard Terms Internal controlled vocabularies for pharmaceutical dose forms Version 1.1.0 16 January 2018 State of matter Basic dose form Release characteristics Transformation ID Name ID Name ID

More information

Microbiological Consideration for Non-Sterile Pharmaceutical

Microbiological Consideration for Non-Sterile Pharmaceutical May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control

More information

Pharmaceutical Sciences

Pharmaceutical Sciences SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE:

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit - FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: DEVELOPMENT PHARMACEUTICS FOR VETERINARY

More information

PQRI Research Project Proposal: Reporting and Qualification Thresholds for Leachables in Parenteral and Ophthalmic Drug Products

PQRI Research Project Proposal: Reporting and Qualification Thresholds for Leachables in Parenteral and Ophthalmic Drug Products PQRI Research Project Proposal: Reporting and Qualification Thresholds for Leachables in Parenteral and Ophthalmic Drug Products Prepared by: Doug Ball (Pfizer), Diane Paskiet (West-Monarch), Daniel L.

More information

International Journal of Pharma and Bio Sciences IMPACT OF SOFT GELATIN CAPSULES FORMULATIONS FOR ORAL ADMINISTRATION ABSTRACT

International Journal of Pharma and Bio Sciences IMPACT OF SOFT GELATIN CAPSULES FORMULATIONS FOR ORAL ADMINISTRATION ABSTRACT Review Article Pharmaceutics International Journal of Pharma and Bio Sciences ISSN 0975-6299 IMPACT OF SOFT GELATIN CAPSULES FORMULATIONS FOR ORAL ADMINISTRATION BODAVULA.SAMBA SIVA RAO Khammam college

More information

CHAPTER 8: SOLID DOSAGE FORM COATING TECHNOLOGY NOOR MUHAMMAD SYAHRIN BIN YAHYA INTRODUCTION

CHAPTER 8: SOLID DOSAGE FORM COATING TECHNOLOGY NOOR MUHAMMAD SYAHRIN BIN YAHYA INTRODUCTION CHAPTER 8: SOLID DOSAGE FORM COATING TECHNOLOGY NOOR MUHAMMAD SYAHRIN BIN YAHYA INTRODUCTION INTRODUCTION Coating technology is used extensively in the pharmaceutical industry, e.g. for the application

More information

Hermes_highlights_need_for_better_formats_OTCBulletin_ pdf. Published July Accessed July 10, 2016.

Hermes_highlights_need_for_better_formats_OTCBulletin_ pdf. Published July Accessed July 10, 2016. Introduction An online survey conducted in the United States found that 50% of surveyed American adults (N = 1002) reported difficulty swallowing tablets and capsules. 1 These numbers are even higher in

More information

SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE

SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE Available online at www.ijdra.com REVIEW ARTICLE 1 Ashara Kalpesh C*, 2 Mendapara Vishal P, 2,3 Mori Nitin M, 4 Badjatya

More information

Meeting Solid Dose Formulation Challenges

Meeting Solid Dose Formulation Challenges Streamlining (Fast Tracking) Solid Dosage Form Development Tony Carpanzano, B.S., R. Ph. Director, Research & Development Streamlining (Fast Tracking) Solid Dosage Form Development Meeting Solid Dose Formulation

More information

Excipient Development at NCL

Excipient Development at NCL New Reverse Enteric Polymer for Oral Dosage Forms Excipient Development at omplete Solution for Taste Masking Moisture Barrier Sustained Release Immediate Release Polymorphism Inhibition National hemical

More information

Dosage Form Design and Development

Dosage Form Design and Development Clinical Therapeutics/Volume 30, Number 11, 2008 Dosage Form Design and Development Loyd V. Allen, Jr., PhD, RPh InternationalJournal ofpharmaceutical Compounding Inc., Edmond, Oklahoma ABSTRACT Background:

More information

Golla and Rao, IJPSR, 2011; Vol. 2(10): ISSN:

Golla and Rao, IJPSR, 2011; Vol. 2(10): ISSN: IJPSR (2011), Vol. 2, Issue 10 (Research Article) Received on 06 June, 2011; received in revised form 10 July, 2011; accepted 28 September, 2011 DEVELOPMENT OF INTEGRATED INDUSTRIAL PROCESS LAYOUT DESIGN

More information

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels

More information

MARIFARM LLC PRODUCTION ABOUT US

MARIFARM LLC PRODUCTION ABOUT US MARIFARM LLC PRODUCTION ABOUT US 2018 KEY INFORMATION COMPANY NAME: HEADQUARTERS: OWNERSHIP: SHARE CAPITAL: SHARE CAPITAL: FOUNDED: Marifarm LLC Maribor, Slovenia (EU) 100% ARTERIUM International BV 4.539.731,46

More information

Evolution of Oil Where Did the Cutbacks Go? North Dakota Asphalt Conference 2019

Evolution of Oil Where Did the Cutbacks Go? North Dakota Asphalt Conference 2019 Evolution of Oil Where Did the Cutbacks Go? North Dakota Asphalt Conference 2019 Role of Asphalt Binder in Chip Seal Asphalt acts as an adhesive To allow aggregate to adhere to the road Role of Asphalt

More information

Application as liquid carrier

Application as liquid carrier Application as liquid carrier Calcium Silicate FLORITE 1 Features High liquid absorbency and great compressibility derived from specific pore structure Stable liquid uniformity in powder with simple method

More information

Development of paediatric formulations - points to consider

Development of paediatric formulations - points to consider Development of paediatric formulations - points to consider Workshop on Paediatric Formulations II London, 8 November 2011 Presented by: Ann Marie Kaukonen Scientific Administrator, Paediatric Medicines,

More information

ADVANTAGES OF MULTIPARTICULATES (PELLETS):

ADVANTAGES OF MULTIPARTICULATES (PELLETS): INTRODUCTION: Multiparticulate Drug Delivery Systems (MDDS): The concept of multiple unit dosage form was initially introduced in the early 1950 s.these forms play a major role in the design of solid dosage

More information

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form. The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form. Three major needs that the formulation into a specific dosage form directly address

More information

Tips & Hints for Quality Compounding - Part III

Tips & Hints for Quality Compounding - Part III VOLUME 16 NUMBER 2 Secundum Artem Current & Practical Compounding Information for the Pharmacist. An ongoing CE Program provided by a grant from Paddock Laboratories, Inc. Tips & Hints for Quality Compounding

More information

PHARMACEUTICAL EXCIPIENT MARKET OVERVIEW AND OUTLOOK

PHARMACEUTICAL EXCIPIENT MARKET OVERVIEW AND OUTLOOK PHARMACEUTICAL EXCIPIENT MARKET OVERVIEW AND OUTLOOK NOVEMBER, 2017 INTRODUCTION Table of Contents COPYRIGHT AND USAGE GUIDELINES...4 INTRODUCTION...5 Methodology...7 How to Read this Report...9 Respondent

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 15, 2011 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

TEPZZ A_T EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art.

TEPZZ A_T EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art. (19) TEPZZ 666764A_T (11) EP 2 666 764 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 13(4) EPC (43) Date of publication: 27.11.13 Bulletin 13/48 (21) Application number: 1273678.1

More information

Modern Pharmaceutics. Second Edition, Revised and Expanded. edited by GILBERT S. BANKER University of Minnesota Minneapolis, Minnesota

Modern Pharmaceutics. Second Edition, Revised and Expanded. edited by GILBERT S. BANKER University of Minnesota Minneapolis, Minnesota Modern Pharmaceutics Second Edition, Revised and Expanded edited by GILBERT S. BANKER University of Minnesota Minneapolis, Minnesota CHRISTOPHER T. RHODES : ' University of Rhode Island Kingston, Rhode

More information

Pharma Ingredients & Services. Ludiflash. Technical Information

Pharma Ingredients & Services. Ludiflash. Technical Information Technical Information Ludiflash March 2012 Supersedes issue dated August 2011 03_070805e-03/Page 1 of 10 = Registered trademark of BASF group Excipient for fast-disintegrating oral dosage forms Direct

More information

Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications Pharma & Food Solutions ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications ETHOCEL Premium Polymers are essentially tasteless, colorless, odorless, noncaloric

More information

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma Roller compactors for the pharmaceutical industry BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma Roller compactors for the pharmaceutical industry Compaction and granulation in the pharmaceutical

More information

Pharma Ingredients & Services. Kollicoat IR White. Technical Information

Pharma Ingredients & Services. Kollicoat IR White. Technical Information Technical Information Kollicoat IR White August 2008 Supersedes issue dated June 2008 EMP 040901e-10/Page 1 of 12 = Registered trademark of BASF SE Ready-to-use coating for instant-release dosage forms

More information

Manufacture of Granulations Part 4. Industrial pharmacy 5 th class 1 st semester

Manufacture of Granulations Part 4. Industrial pharmacy 5 th class 1 st semester Manufacture of Granulations Part 4 Industrial pharmacy 5 th class 1 st semester Dry manufacturing methods The manufacture of granulations for tablet compression may follow one or a combination of three

More information

Pharma Ingredients & Services. Ludiflash. Technical Information

Pharma Ingredients & Services. Ludiflash. Technical Information Technical Information Ludiflash April 2008 Supersedes issue dated September 2007 EMP 070805e-01/Page 1 of 12 = Registered trademark of BASF SE Excipient for fast-disintegrating oral dosage forms Direct

More information

ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT

ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT Update revision : 22 February 2005. 9 th ACCSQ-PPWG Meeting, Philippines, 21-24 Feb 2005 LIST OF CONTENTS 1. INTRODUCTION 1 2. OBJECTIVES 1 3. SCOPES

More information

Quality is Our Promise.

Quality is Our Promise. Quality is Our Promise. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program

More information

The Basics of Alkaline In-Process Cleaning. for Metal Substrates. John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey

The Basics of Alkaline In-Process Cleaning. for Metal Substrates. John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey The Basics of Alkaline In-Process Cleaning for Metal Substrates John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey This paper pertains mainly to alkaline cleaners, but includes solvents and

More information

GUIDANCE DOCUMENT Use of a Foreign-sourced Reference Product as a Canadian Reference Product

GUIDANCE DOCUMENT Use of a Foreign-sourced Reference Product as a Canadian Reference Product GUIDANCE DOCUMENT Use of a Foreign-sourced Reference Product as a Canadian Reference Product Published by authority of the Minister of Health Date Adopted 2017/11/24 Effective Date 2017/11/24 Health Products

More information

Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education

Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International

More information

QbD in developing semisolid formulations

QbD in developing semisolid formulations QbD in developing semisolid formulations 4th Jerusalem Conference on Quality and Pharma Sciences Haim Barsimantov, COO, Sol-Gel 21.05.13 Outline Drug Product Specification - definition In Process Control

More information

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: Review Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com REVIEW ARTICLE ON INPROCESS PROBLEMS AND EVALUATION TESTS

More information

USE OF SPHERICAL TECHNOLOGIES

USE OF SPHERICAL TECHNOLOGIES USE OF SPHERICAL TECHNOLOGIES USE OF SPHERICAL TECHNIQUES Spherical techniques are widely used to make particles spherical since spherical shape possesses properties suitable for their easy manufacturing.

More information

Microfluidizer Processors:

Microfluidizer Processors: 30 Ossipee Road Newton, MA 02464 www.microfluidicscorp.com Microfluidizer Processors: Technology and Applications Presented by: Thomai Mimi Panagiotou, Ph.D. CTO Microfluidics at a Glance Headquartered

More information

3.2 Test for sterility

3.2 Test for sterility This text is based on the internationally-harmonized texts developed by the Pharmacopoeial Discussion Group (PDG). Some editorial modifications have been made in order to be in line with the style used

More information

Adare Pharmaceuticals. A partnership that adds value to your products

Adare Pharmaceuticals. A partnership that adds value to your products Adare Pharmaceuticals Adare Pharmaceuticals provides enhanced medicines, creating new possibilities for improved patient health. Our vision to expand Building upon our legacy, we strive to reshape medicines

More information

MINISTRY OF HEALTH AND SOCIAL SERVICES

MINISTRY OF HEALTH AND SOCIAL SERVICES MINISTRY OF HEALTH AND SOCIAL SERVICES NAMIBIA MEDICINES REGULATORY COUNCIL POST REGISTRATION AMENDMENT GUIDELINES These guidelines are meant to provide assistance to industry and health care professionals

More information

EMCOMPRESS. Calcium Hydrogen Phosphate, Ph.Eur., E 341(ii) Dibasic Calcium Phosphate, USP/NF, FCC. A Proven Excipient for more than 60 Years

EMCOMPRESS. Calcium Hydrogen Phosphate, Ph.Eur., E 341(ii) Dibasic Calcium Phosphate, USP/NF, FCC. A Proven Excipient for more than 60 Years EMCOMPRESS Calcium Hydrogen Phosphate, Ph.Eur., E 31(ii) Dibasic Calcium Phosphate, USP/NF, FCC A Proven Excipient for more than 60 Years Functional Filler Flow Enhancer for High Speed Tableting Calcium

More information

Medicine Variations Guideline

Medicine Variations Guideline Medicine Variations Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain 30 th March 2017 Version 2.0 Chief of Pharmaceutical Product Regulation: Dr/Roaya Al Abbasi Date: NHRA CEO Approval:

More information

Medicines Variations Guideline

Medicines Variations Guideline Medicines Variations Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain 27/08/2014 Version 1.1 Chief of Pharmaceutical Product Regulation: Dr / Roaya Al Abbasi Date: NHRA CEO Approval:

More information

"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY

NOT FOR IMPLEMENTATION GUIDANCE FOR INDUSTRY "NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo

More information

Providing insight into pharmaceutical formulations

Providing insight into pharmaceutical formulations Providing insight into pharmaceutical formulations Dr Steve Ward-Smith Pharmaceutical Industry The average cost of developing a drug is reported to be approx $500 million, but up to 70% of new chemical

More information

Preformulation. By: Ass. Prof. Gamal Shazly

Preformulation. By: Ass. Prof. Gamal Shazly Preformulation By: Ass. Prof. Gamal Shazly Preformulation Testing It is the investigation of the physical and the chemical properties of the drug substance alone and when combined with formulating excipients

More information

Thermostable Biopharmaceuticals For Delivery Without Reconstitution

Thermostable Biopharmaceuticals For Delivery Without Reconstitution Thermostable Biopharmaceuticals For Delivery Without Reconstitution V. Bronshtein Supported by NIH Grants U01AI070350, 5R44AI080035, 5R21AI094508, and CDC Contract Number 200-2012-53276 Bottlenecks for

More information

Blank Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets) Ingredient Listing Qty. Unit NDC # Supplier. 0.

Blank Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets) Ingredient Listing Qty. Unit NDC # Supplier. 0. 4/19/2015; Page 1 SUGGESTED FORMULATION APIs* Ingredient Listing Qty. Unit NDC # Supplier Orange Flavor (Powder) 0.40 g Stevia Powder (Stevioside) 0.20 g Bitterness Reducing Agent (NF01) Natural (Powder)**

More information

TABLET COATING. Lec. 8

TABLET COATING. Lec. 8 TABLET COATING Lec. 8 TABLET COATING PRINCIPLES History: Tab. coating starts with Rhazes (coated food) in 800s then developed by Frenches (sugar coat) in 1800s and finally Abbott marketed (film coat) in

More information

SIZE REDUCTION. Subject:Pharmaceutical Engineering Course:II B.Pharm I Sem Presented by Mr.C.Kishore M.Pharm(Pharmaceutics)

SIZE REDUCTION. Subject:Pharmaceutical Engineering Course:II B.Pharm I Sem Presented by Mr.C.Kishore M.Pharm(Pharmaceutics) SIZE REDUCTION Subject:Pharmaceutical Engineering Course:II B.Pharm I Sem Presented by Mr.C.Kishore M.Pharm(Pharmaceutics) CONTENTS INTRODUCTION CLASSIFICATION TECHNIQUES ROTARY CUTTER MILL MORTAR AND

More information

Technical Bulletin MC-25. Microcrystalline Cellulose

Technical Bulletin MC-25. Microcrystalline Cellulose Technical Bulletin MC-25 Microcrystalline Cellulose n n MICRCEL Introduction Microcel Microcrystalline Cellulose is the preferred excipient for use in tablet, capsule, granule, pellet, sphere, and adsorption

More information

Asphalt is found in natural deposits in different parts of the world or as a product of the distillation of crude petroleum.

Asphalt is found in natural deposits in different parts of the world or as a product of the distillation of crude petroleum. Introduction Bituminous materials are widely used all over the world in highway construction. These hydrocarbons are found in natural deposits or are obtained as a product of the distillation of crude

More information

Kollicoat IR. The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms. ExcipientFest.

Kollicoat IR. The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms. ExcipientFest. Kollicoat IR The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms ExcipientFest Nigel Langley Market Need Platforms Instant & Modified Release Solubilization Skin

More information

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and

More information

INNOVATIVE COMPOUNDING SERVICES

INNOVATIVE COMPOUNDING SERVICES INNOVATIVE COMPOUNDING SERVICES We are excited to introduce our innovative compounded oral rinses that may offer a safe and effective alternative for the management of side effects associated with chemotherapy

More information

Maximizing Roller Compaction Benefits with Proper Excipient Selection

Maximizing Roller Compaction Benefits with Proper Excipient Selection A sponsored whitepaper. Maximizing Roller Compaction Benefits with Proper Excipient Selection By: Bernhard Fussnegger, Global Development and Technical Marketing, PVP/Coatings, Instant & Modified Release,

More information

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients ExcipientFest Americas, San Juan, PR April 29 th 2015 Dr. Carolina Diaz Quijano_ carolina.diazquijano@omya.com

More information

Q8 Pharmaceutical Development

Q8 Pharmaceutical Development Q8 Pharmaceutical Development For questions regarding this draft document contact (CDER) Ajaz Hussain at 301-594-2847 or (CBER) Christopher Joneckis at 301-435-5681. This draft guidance, when finalized,

More information

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability 2017 WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability Eric C Buxton Clinical Associate Professor University of Wisconsin Madison School of Pharmacy, Division of Pharmacy

More information

Next Generation Pharma Solutions

Next Generation Pharma Solutions 02/2008 For product development, clinical trials services, contract manufacturing and cold chain and logistics services partner with NextPharma Next Generation Pharma Solutions www.nextpharma.com Next

More information

Roles And Applications of Cellulose Ether in Environmentally Friendly. Building Materials

Roles And Applications of Cellulose Ether in Environmentally Friendly. Building Materials Roles And Applications of Cellulose Ether in Environmentally Friendly Building Materials Overview of Cellulose Ether Cellulose ether is a kind of non-ionic semi-synthetic polymer, and has two kinds, water

More information